550 Robotic Totally Endoscopic Mitral Valve Surgeries within a Comprehensive Robotic Cardiac Program

Hiroto Kitahara,Sarah Nisivaco,Riya Bhasin,Ibraheem Hamzat,Kaitlin Grady,Husam H Balkhy
DOI: https://doi.org/10.1016/j.athoracsur.2024.08.005
2024-08-24
Abstract:Background: In 2013, we initiated a comprehensive multi-spectrum robotic cardiac surgery program with emphasis on the totally-endoscopic approach. We reviewed the outcomes of mitral valve (MV) procedures within this context. Methods: A retrospective review of 1714 robotic endoscopic cardiac surgeries performed at our institution between September 2013 and February 2024 was conducted. Of these, outcomes of 550 consecutive heterogenous patients undergoing robotic totally-endoscopic MV operations were analyzed. Data were collected according to the Mitral Valve Academic Research Consortium (MVARC) definitions. Results: The mean age was 63 years and 217 patients (39%) were female. The mean STS risk of mortality was 2.1% [range 0.15-19.4]. MV repair occurred in 98% of patients with degenerative mitral regurgitation (MR). Concomitant procedures included: Cox-maze cryo-ablation in 127 (23%) patients; tricuspid valve repair in 54 (9.8%); septal myectomy in 15 (2.7%), totally endoscopic coronary bypass in 6 (1.1%) and aortic valve replacement in 3 (0.5%). Endo-aortic balloon occlusion was used in 392 patients (71%), ventricular fibrillatory arrest in 114 (21%) and trans-thoracic aortic clamp in 44 (8%). Observed-to-expected thirty-day mortality was 0.6. Mean length of hospital stay was 2.8 days. MV repair 30-day surgical success was 95.9% and procedural success was 93.0%. Post-operative echo revealed trace/no residual MR in 95% and mild residual MR in 5%. Five-year freedom from re-operation for recurrent MR was 95.7%. Conclusions: Robotic endoscopic MV surgery is feasible within the context of a comprehensive multi-spectrum robotic cardiac surgery program.
What problem does this paper attempt to address?